Commonwealth Equity Services’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $121K | Sell |
53,243
-1,000
| -2% | -$2.27K | ﹤0.01% | 4029 |
|
|
2025
Q1 | $34K | Buy |
54,243
+1,000
| +2% | +$627 | ﹤0.01% | 4095 |
|
|
2024
Q4 | $55K | Sell |
53,243
-1,000
| -2% | -$1.03K | ﹤0.01% | 3975 |
|
|
2024
Q3 | $64K | Hold |
54,243
| – | – | ﹤0.01% | 3911 |
|
|
2024
Q2 | $66K | Buy |
54,243
+1,000
| +2% | +$1.22K | ﹤0.01% | 3869 |
|
|
2024
Q1 | $116K | Hold |
53,243
| – | – | ﹤0.01% | 3764 |
|
|
2023
Q4 | $83K | Hold |
53,243
| – | – | ﹤0.01% | 3699 |
|
|
2023
Q3 | $69K | Hold |
53,243
| – | – | ﹤0.01% | 3624 |
|
|
2023
Q2 | $92K | Hold |
53,243
| – | – | ﹤0.01% | 3588 |
|
|
2023
Q1 | $80 | Hold |
53,243
| – | – | ﹤0.01% | 3525 |
|
|
2022
Q4 | $85K | Buy |
+53,243
| New | +$85K | ﹤0.01% | 3437 |
|